Preview

Cardiovascular Therapy and Prevention

Advanced search

Modern potential of thrombotic complication prevention among patients with acute coronary syndrome without ST segment elevation in real clinical practice (Part I)

Abstract

Aim. To compare therapeutic and diagnostic measures, as well as the incidence of cardiovascular events (CVE), during hospitalization, one-year and five-year follow-up period among the patients with acute coronary syndrome without ST segment elevation (non-STE ACS), who were urgently hospitalized to a therapy department of a large multi-field hospital, or to a specialised cardiology department. This comparison was aimed at identifying the methods for further medical service optimization. Material and methods. This retrospective, historical cohort study included 350 consecutive medical histories of non-STE ACS patients, urgently hospitalized to the urgent cardiology department (Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences), and 370 medical histories of the patients hospitalized to the therapy department (City Hospital No. 1). Results. In the therapy department, non-STE ACS patients received fewer diagnostic and therapeutic procedures than in the cardiology department, due to limited resources. The risk levels at in- and out-patient treatment stages were not assessed adequately, which resulted in a higher incidence of adverse outcomes throughout the follow-up period. Original clopidogrel was administered to 6 % and 0 % of the cardiology and therapy department patients, respectively. Since there is no statistically significant difference in hard outcomes between original and generic clopidogrel (Zyllt), the latter could be recommended to ACS patients. Conclusion. Non-STE ACS patients with high risk should be referred to specialised cardiology hospitals, where invasive diagnostic and treatment (percutaneous coronary intervention) could be performed. High effectiveness and good safety profile should improve Zyllt treatment compliance in most patients after ACS and/or revascularization.

About the Authors

T. M. Poponina
Siberian State Medical University
Russian Federation


Yu. S. Poponina
Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences. Tomsk
Russian Federation


References

1. Баркаган З.С., Момот А.П. Диагностика и контролируемая терапия нарушений гемостаза. М.: Ньюдиамед 2001; 296 с.

2. Попонина Т.М., Попонина Ю.С., Капилевич Н.А. Оптимизация лечения больных с острым коронарным синдромом без подъема сегмента ST. Кардиоваск тер про-фил 2009; 7: 49-58.

3. Попонина Т.М., Попонина Ю.С., Капилевич Н.А., Ефимова Е.В. Современные подходы к профилактике тромботических осложнений у больных с острым коронарным синдромом без подъема сегмента ST. Актуал вопр бол серд сосуд 2009; 4(4): 4-9.

4. Попонина Т.М. Патогенетические аспекты лечения острого коронарного синдрома без подъема сегмента ST. Сибир мед ж 2003; 1-2: 77-83.

5. Рекомендации по лечению острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ. Приложение 1 к журналу «Кардиоваскулярная терапия и профилактика» 2006; 8(5): 1-29.

6. Эрлих А.Д., Грацианский Н.А. и участники регистра РЕКОРД. Лечение больных острым коронарным синдромом с подъемом ST в стационарах, имеющих и не имеющих возможности выполнения чрескожных коронарных вмешательств (данные регистра «РЕКОРД»). Атеротромбоз 2009; 1(2): 120-2.

7. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Guideline Revision. JACC 2007; 50(7): e1-15.

8. Bassand J-P, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007; 28: 1598-660.

9. Bijsterveld NR, Moons AH, Meijers JC, et al. Rebound

10. thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and lowmolecular-weight heparin. JACC 2002; 39(5): 811-7.

11. Birkhead JS, Walker L, Pearson M, et al. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart 2004; 90: 1004-9.

12. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Comitee on Prevention, Detection, Evalution, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560-72.

13. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-33.

14. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23: 1177-89.

15. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 1329-39.

16. Kesselheim AS, Misono AS, Lee JL, et al. Clinical Equivalence of Generic and Brand- Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis. JAMA 2008; 300(21): 2514-26.

17. Lev EI, Battler A, Behar S, et al. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. Am J Cardiol 2003; 91: 224-7.

18. Terkelsen CJ, Lassen JF, Norgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005; 26: 18-26.


Review

For citations:


Poponina T.M., Poponina Yu.S. Modern potential of thrombotic complication prevention among patients with acute coronary syndrome without ST segment elevation in real clinical practice (Part I). Cardiovascular Therapy and Prevention. 2010;9(8):4-11. (In Russ.)

Views: 506


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)